| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3438243 | American Journal of Obstetrics and Gynecology | 2007 | 9 Pages |
Abstract
The outcome of the trial did not conclusively determine whether AR or SFLP is a superior treatment modality. TTTS cardiomyopathy appears to be an important factor in recipient survival in TTTS.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Timothy M. MD, David ScD, Hanmin MD, Mark MD, Mary MD, Flint MD, Jacquelyn MD, Richard MD, Alfred MD, George MD, Laurence MD, David MD, Joanne MD, Craig T. MD, Ray MD, Robert H. MD, Larissa MD, Beverly MD, Bruce MD,